Cargando…

Development of an indirect ELISA for detection of anti-Mycoplasma hyopneumoniae IgG in naturally infected pathogen-induced convalescent sera

BACKGROUND: Immunization of pigs with an inactivated Mycoplasma hyopneumoniae vaccine (bacterin) generates hyperimmune serum that contains high concentrations of anti-M. hyopneumoniae IgG. Commercially available IgG-ELISA kits cannot distinguish between anti-M. hyopneumoniae IgG in inactivated bacte...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yaqin, Xu, Zuobo, Wen, Yukang, Yang, Mei, Ning, Yaru, Wang, Zhaodi, Ding, Honglei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968261/
https://www.ncbi.nlm.nih.gov/pubmed/33726780
http://dx.doi.org/10.1186/s12917-021-02828-7
_version_ 1783666028401655808
author Tian, Yaqin
Xu, Zuobo
Wen, Yukang
Yang, Mei
Ning, Yaru
Wang, Zhaodi
Ding, Honglei
author_facet Tian, Yaqin
Xu, Zuobo
Wen, Yukang
Yang, Mei
Ning, Yaru
Wang, Zhaodi
Ding, Honglei
author_sort Tian, Yaqin
collection PubMed
description BACKGROUND: Immunization of pigs with an inactivated Mycoplasma hyopneumoniae vaccine (bacterin) generates hyperimmune serum that contains high concentrations of anti-M. hyopneumoniae IgG. Commercially available IgG-ELISA kits cannot distinguish between anti-M. hyopneumoniae IgG in inactivated bacterin-induced hyperimmune sera and convalescent sera resulting from natural M. hyopneumoniae infection. Establishment of an ELISA to detect anti-M. hyopneumoniae IgG in convalescent sera will facilitate the evaluation of the M. hyopneumoniae status of pig farms. RESULTS: In this study, we expressed and purified recombinant Mhp366-N protein, which contains an epitope recognized by M. hyopneumoniae convalescent sera but not hyperimmune sera, for use as a coating antigen. For the M. hyopneumoniae convalescent serum IgG-ELISA, the optimal antigen concentration, blocking buffer, blocking time, dilution of serum, incubation time with serum, secondary antibody dilution, secondary antibody incubation time and colorimetric reaction time were 0.25 µg/mL, 2.5 % skim milk, 1 h, 1:500, 0.5 h, 1:10,000, 1 h and 15 min, respectively. Validation of the M. hyopneumoniae convalescent serum IgG-ELISA showed a cut-off value of 0.323, the intra-assay CV ranged from 3.27 to 7.26 %, the inter-assay CV ranged from 3.46 to 5.93 %, and the assay was able to differentiate convalescent sera from antibodies to 7 other porcine respiratory pathogens. The convalescent serum IgG-ELISA detected no anti-M. hyopneumoniae IgG in hyperimmune serum samples while a commercial IgG-ELISA identified 95/145 of these sera as positive. The accuracy of the M. hyopneumoniae convalescent serum IgG-ELISA was comparable to the sIgA-ELISA but better than the commercial IgG-ELISA. CONCLUSIONS: The convalescent serum IgG-ELISA is a reproducible, sensitive, and specific indirect ELISA to detect anti-M. hyopneumoniae IgG in naturally infected pathogen-induced convalescent sera. This ELISA could be used to carry out large scale surveillance of M. hyopneumoniae infection in pig farms regardless of vaccination status.
format Online
Article
Text
id pubmed-7968261
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79682612021-03-22 Development of an indirect ELISA for detection of anti-Mycoplasma hyopneumoniae IgG in naturally infected pathogen-induced convalescent sera Tian, Yaqin Xu, Zuobo Wen, Yukang Yang, Mei Ning, Yaru Wang, Zhaodi Ding, Honglei BMC Vet Res Methodology Article BACKGROUND: Immunization of pigs with an inactivated Mycoplasma hyopneumoniae vaccine (bacterin) generates hyperimmune serum that contains high concentrations of anti-M. hyopneumoniae IgG. Commercially available IgG-ELISA kits cannot distinguish between anti-M. hyopneumoniae IgG in inactivated bacterin-induced hyperimmune sera and convalescent sera resulting from natural M. hyopneumoniae infection. Establishment of an ELISA to detect anti-M. hyopneumoniae IgG in convalescent sera will facilitate the evaluation of the M. hyopneumoniae status of pig farms. RESULTS: In this study, we expressed and purified recombinant Mhp366-N protein, which contains an epitope recognized by M. hyopneumoniae convalescent sera but not hyperimmune sera, for use as a coating antigen. For the M. hyopneumoniae convalescent serum IgG-ELISA, the optimal antigen concentration, blocking buffer, blocking time, dilution of serum, incubation time with serum, secondary antibody dilution, secondary antibody incubation time and colorimetric reaction time were 0.25 µg/mL, 2.5 % skim milk, 1 h, 1:500, 0.5 h, 1:10,000, 1 h and 15 min, respectively. Validation of the M. hyopneumoniae convalescent serum IgG-ELISA showed a cut-off value of 0.323, the intra-assay CV ranged from 3.27 to 7.26 %, the inter-assay CV ranged from 3.46 to 5.93 %, and the assay was able to differentiate convalescent sera from antibodies to 7 other porcine respiratory pathogens. The convalescent serum IgG-ELISA detected no anti-M. hyopneumoniae IgG in hyperimmune serum samples while a commercial IgG-ELISA identified 95/145 of these sera as positive. The accuracy of the M. hyopneumoniae convalescent serum IgG-ELISA was comparable to the sIgA-ELISA but better than the commercial IgG-ELISA. CONCLUSIONS: The convalescent serum IgG-ELISA is a reproducible, sensitive, and specific indirect ELISA to detect anti-M. hyopneumoniae IgG in naturally infected pathogen-induced convalescent sera. This ELISA could be used to carry out large scale surveillance of M. hyopneumoniae infection in pig farms regardless of vaccination status. BioMed Central 2021-03-16 /pmc/articles/PMC7968261/ /pubmed/33726780 http://dx.doi.org/10.1186/s12917-021-02828-7 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Methodology Article
Tian, Yaqin
Xu, Zuobo
Wen, Yukang
Yang, Mei
Ning, Yaru
Wang, Zhaodi
Ding, Honglei
Development of an indirect ELISA for detection of anti-Mycoplasma hyopneumoniae IgG in naturally infected pathogen-induced convalescent sera
title Development of an indirect ELISA for detection of anti-Mycoplasma hyopneumoniae IgG in naturally infected pathogen-induced convalescent sera
title_full Development of an indirect ELISA for detection of anti-Mycoplasma hyopneumoniae IgG in naturally infected pathogen-induced convalescent sera
title_fullStr Development of an indirect ELISA for detection of anti-Mycoplasma hyopneumoniae IgG in naturally infected pathogen-induced convalescent sera
title_full_unstemmed Development of an indirect ELISA for detection of anti-Mycoplasma hyopneumoniae IgG in naturally infected pathogen-induced convalescent sera
title_short Development of an indirect ELISA for detection of anti-Mycoplasma hyopneumoniae IgG in naturally infected pathogen-induced convalescent sera
title_sort development of an indirect elisa for detection of anti-mycoplasma hyopneumoniae igg in naturally infected pathogen-induced convalescent sera
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968261/
https://www.ncbi.nlm.nih.gov/pubmed/33726780
http://dx.doi.org/10.1186/s12917-021-02828-7
work_keys_str_mv AT tianyaqin developmentofanindirectelisafordetectionofantimycoplasmahyopneumoniaeigginnaturallyinfectedpathogeninducedconvalescentsera
AT xuzuobo developmentofanindirectelisafordetectionofantimycoplasmahyopneumoniaeigginnaturallyinfectedpathogeninducedconvalescentsera
AT wenyukang developmentofanindirectelisafordetectionofantimycoplasmahyopneumoniaeigginnaturallyinfectedpathogeninducedconvalescentsera
AT yangmei developmentofanindirectelisafordetectionofantimycoplasmahyopneumoniaeigginnaturallyinfectedpathogeninducedconvalescentsera
AT ningyaru developmentofanindirectelisafordetectionofantimycoplasmahyopneumoniaeigginnaturallyinfectedpathogeninducedconvalescentsera
AT wangzhaodi developmentofanindirectelisafordetectionofantimycoplasmahyopneumoniaeigginnaturallyinfectedpathogeninducedconvalescentsera
AT dinghonglei developmentofanindirectelisafordetectionofantimycoplasmahyopneumoniaeigginnaturallyinfectedpathogeninducedconvalescentsera